Posted by admin on May 18th, 2012

Carotid ultrasound in the ...

  Abstract Adequate stratification of cardiovascular (CV) risk is one of the major points of interest in the management of patients with rheumatoid arthritis (RA). A task force of the European League Against Rheumatism has proposed to adapt CV risk management calculated in RA patients according to the systematic coronary risk evaluation (SCORE) function by application of a multiplier factor of 1.5 in...

Posted by admin on May 10th, 2012

The risks of smoking in pa...

  The smoking prevalence in Europe varies from 14% in Sweden to nearly 38% in Greece.1 In the USA it is now approximately 20%, with large differences between states and according to social class and ethnic background.2 The proportions of men and women smoking is rather variable, but the relative risk of cardiovascular diseases seems to be higher in women.3 Smoking prevalence decreases with higher...

Posted by admin on May 8th, 2012

Smokers in early axial spo...

  Objectives To investigate the association of smoking with various clinical, functional and imaging outcomes in patients with early axial spondyloarthritis (SpA). Methods 647 patients with early inflammatory back pain (IBP) fulfilling at least one of the internationally accepted SpA criteria and with available smoking data were included in the analyses. Clinical, demographic and imaging parameters...

Posted by admin on May 7th, 2012

Rheumatoid arthritis disea...

Introduction Although the systematic measurement of disease activity facilitates clinical decision making in rheumatoid arthritis (RA), no recommendations currently exist on which measures should be applied in clinical practice in the US. The American College of Rheumatology (ACR) convened a Working Group (WG) to comprehensively evaluate the validity, feasibility, and acceptability of available RA disease...

Posted by admin on May 4th, 2012

Bone loss associated with ...

  Aromatase inhibitors are the standard of care for the treatment of most postmenopausal women with early stage hormone-receptor-positive breast cancer. 1 These drugs, in general, have a favourable side-effect profile, and are not associated with increased gynaecological or thromboembolism risks compared with selective oestrogen receptor modulators. The side-effects of aromatase inhibitors relate to the...

Posted by admin on May 3rd, 2012

Postmenopausal osteoporosi...

  Abstract Osteoporosis may be a lifelong condition. Robust data regarding the efficacy and safety of both long?term osteoporosis therapy and therapy discontinuation are therefore important. A paucity of clinical trial data regarding the long?term antifracture efficacy of osteoporosis therapies necessitates the use of surrogate endpoints in discussions surrounding long?term use and/or discontinuation....